vs
Side-by-side financial comparison of Enova International, Inc. (ENVA) and STEPAN CO (SCL). Click either name above to swap in a different company.
Enova International, Inc. is the larger business by last-quarter revenue ($875.1M vs $604.5M, roughly 1.4× STEPAN CO). Enova International, Inc. runs the higher net margin — 10.4% vs 3.3%, a 7.1% gap on every dollar of revenue. On growth, Enova International, Inc. posted the faster year-over-year revenue change (17.4% vs 1.9%). Over the past eight quarters, Enova International, Inc.'s revenue compounded faster (18.0% CAGR vs 4.2%).
Enova International, Inc. is a global fintech firm providing online financial solutions including short-term consumer loans and small business financing. It operates mainly across North America, South America and Europe, using advanced data analytics to assess creditworthiness and deliver tailored products to underserved borrower segments.
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
ENVA vs SCL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $875.1M | $604.5M |
| Net Profit | $91.1M | $19.7M |
| Gross Margin | — | 10.7% |
| Operating Margin | 23.7% | 4.7% |
| Net Margin | 10.4% | 3.3% |
| Revenue YoY | 17.4% | 1.9% |
| Net Profit YoY | 24.9% | — |
| EPS (diluted) | $3.46 | $0.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $875.1M | $604.5M | ||
| Q4 25 | $839.4M | $553.9M | ||
| Q3 25 | $802.7M | $590.3M | ||
| Q2 25 | $764.0M | $594.7M | ||
| Q1 25 | $745.5M | $593.3M | ||
| Q4 24 | $729.6M | $525.6M | ||
| Q3 24 | $689.9M | $546.8M | ||
| Q2 24 | $628.4M | $556.4M |
| Q1 26 | $91.1M | $19.7M | ||
| Q4 25 | $79.0M | $5.0M | ||
| Q3 25 | $80.3M | $10.8M | ||
| Q2 25 | $76.1M | $11.3M | ||
| Q1 25 | $72.9M | $19.7M | ||
| Q4 24 | $63.7M | $3.4M | ||
| Q3 24 | $43.4M | $23.6M | ||
| Q2 24 | $53.9M | $9.5M |
| Q1 26 | — | 10.7% | ||
| Q4 25 | 59.8% | 9.3% | ||
| Q3 25 | 57.4% | 12.0% | ||
| Q2 25 | 57.8% | 12.1% | ||
| Q1 25 | 57.2% | 12.7% | ||
| Q4 24 | 56.6% | 10.8% | ||
| Q3 24 | 58.0% | 13.8% | ||
| Q2 24 | 58.9% | 12.5% |
| Q1 26 | 23.7% | 4.7% | ||
| Q4 25 | 22.2% | 1.9% | ||
| Q3 25 | 24.5% | 3.7% | ||
| Q2 25 | 24.1% | 3.0% | ||
| Q1 25 | 23.1% | 4.8% | ||
| Q4 24 | 21.3% | 1.5% | ||
| Q3 24 | 22.3% | 4.4% | ||
| Q2 24 | 23.1% | 3.4% |
| Q1 26 | 10.4% | 3.3% | ||
| Q4 25 | 9.4% | 0.9% | ||
| Q3 25 | 10.0% | 1.8% | ||
| Q2 25 | 10.0% | 1.9% | ||
| Q1 25 | 9.8% | 3.3% | ||
| Q4 24 | 8.7% | 0.6% | ||
| Q3 24 | 6.3% | 4.3% | ||
| Q2 24 | 8.6% | 1.7% |
| Q1 26 | $3.46 | $0.86 | ||
| Q4 25 | $2.94 | $0.22 | ||
| Q3 25 | $3.03 | $0.47 | ||
| Q2 25 | $2.86 | $0.50 | ||
| Q1 25 | $2.69 | $0.86 | ||
| Q4 24 | $2.29 | $0.14 | ||
| Q3 24 | $1.57 | $1.03 | ||
| Q2 24 | $1.93 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.1M | — |
| Total DebtLower is stronger | $4.8B | $328.4M |
| Stockholders' EquityBook value | — | $1.2B |
| Total Assets | $6.9B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $96.1M | — | ||
| Q4 25 | $71.7M | $132.7M | ||
| Q3 25 | $53.6M | $118.5M | ||
| Q2 25 | $55.6M | $88.9M | ||
| Q1 25 | $55.5M | $107.5M | ||
| Q4 24 | $73.9M | $99.7M | ||
| Q3 24 | $67.5M | $147.3M | ||
| Q2 24 | $60.1M | $124.7M |
| Q1 26 | $4.8B | $328.4M | ||
| Q4 25 | $4.5B | $626.7M | ||
| Q3 25 | $4.1B | $655.5M | ||
| Q2 25 | $4.0B | $658.0M | ||
| Q1 25 | $3.8B | $659.3M | ||
| Q4 24 | $3.6B | $625.4M | ||
| Q3 24 | $3.3B | $688.5M | ||
| Q2 24 | $3.2B | $657.1M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B |
| Q1 26 | $6.9B | $2.3B | ||
| Q4 25 | $6.5B | $2.4B | ||
| Q3 25 | $6.0B | $2.4B | ||
| Q2 25 | $5.7B | $2.4B | ||
| Q1 25 | $5.5B | $2.4B | ||
| Q4 24 | $5.3B | $2.3B | ||
| Q3 24 | $5.0B | $2.4B | ||
| Q2 24 | $4.8B | $2.3B |
| Q1 26 | — | 0.28× | ||
| Q4 25 | 3.37× | 0.50× | ||
| Q3 25 | 3.20× | 0.53× | ||
| Q2 25 | 3.23× | 0.53× | ||
| Q1 25 | 3.14× | 0.55× | ||
| Q4 24 | 2.98× | 0.53× | ||
| Q3 24 | 2.79× | 0.56× | ||
| Q2 24 | 2.78× | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENVA
Segment breakdown not available.
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
